Dexamethasone Vs Methylprednisolone for the Treatment of Patients With ARDS Caused by COVID-19
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MD
First Affiliated Hospital Xi'an Jiaotong University
Study Director - Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MD
First Affiliated Hospital Xi'an Jiaotong University
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
2 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Chattogram General Hospital
Chittagong, Bangladesh
Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MDShubhashis Talukder, MBBS, DORecruiting - M. Abdur Rahim Medical College Hospital
Dinajpur, Bangladesh
Abu Taiub Mohammed Mohiuddin Chowdhury, MBBS, MDAkter Kamal, MD, PhDRecruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 2 Aug 2020
- Primary completion
- 15 Nov 2020
- Completion
- 30 Nov 2020
- Last update posted
- 18 Aug 2020
- Registered enrollment
- 60
- Registry id
- NCT04499313
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.